Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ORR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT06574958
What this trial is testing

Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma

Who this might be right for
ORR,OS,PFS
The Second Hospital of Shandong University 10
Testing effectiveness (Phase 2)Study completedNCT01893372
What this trial is testing

Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01915589
What this trial is testing

Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 16
Testing effectiveness (Phase 2)Looking for participantsNCT07072351
What this trial is testing

Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaHypofractionated RadiotherapyImmunotherapy+1 more
West China Hospital 88
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06683885
What this trial is testing

A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Newly Diagnosed Diffuse Large B-cell Lymphoma
Mingzhi Zhang 80
Testing effectiveness (Phase 2)Study completedNCT02090153
What this trial is testing

Study of S-1 Plus LV for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Sun Yat-sen University 39
Not applicableUnknownNCT03336554
What this trial is testing

Epigenetic Biomarker for Osteosarcoma

Who this might be right for
Histologic Response (Tumor Necrosis Rate)Objective Response Rate for Neoadjuvant Chemotherapy, ORRProgression-free Survival, PFS+1 more
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01915602
What this trial is testing

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07328802
What this trial is testing

Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma

Who this might be right for
ORR,OS,PFS
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Testing effectiveness (Phase 2)UnknownNCT04831658
What this trial is testing

A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Mingzhi Zhang 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02586857
What this trial is testing

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Acerta Pharma BV 24
Testing effectiveness (Phase 2)UnknownNCT03279614
What this trial is testing

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Peking University 45
Large-scale testing (Phase 3)Study completedNCT01824459
What this trial is testing

S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

Who this might be right for
Gastric Cancer
Sun Yat-sen University 576
Post-approval studies (Phase 4)UnknownNCT04490590
What this trial is testing

A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma

Who this might be right for
NK/T-Cell Lymphoma
Mingzhi Zhang 30
Not applicableEnrolling By InvitationNCT07449949
What this trial is testing

A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma

Who this might be right for
ORRPFSOS
Eye & ENT Hospital of Fudan University 43
Post-approval studies (Phase 4)Study completedNCT03376958
What this trial is testing

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Relapsed and RefractoryDiffuse Large B Cell Lymphoma
Zhengzhou University 32
Testing effectiveness (Phase 2)UnknownNCT03422029
What this trial is testing

Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients

Who this might be right for
Neuroendocrine Tumors
Peking University 20
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Next Page